"Federal Judge Upholds Medicare's Authority to Negotiate Drug Prices"

A federal court judge in Ohio has denied the US Chamber of Commerce's attempt to block the implementation of Medicare's new drug price negotiation program. The judge ruled that the chamber failed to demonstrate a strong likelihood of success or irreparable harm. The ruling marks the first time a federal court has weighed in on the multiple lawsuits filed against the program. The Biden administration applauded the decision, stating that nothing in the Constitution prohibits Medicare from negotiating drug prices. The program allows Medicare to negotiate the prices of certain expensive drugs, and the first 10 drugs subject to price negotiations have been unveiled. The negotiations will take place over the next year, with the agreed-upon maximum fair prices published by September 2024.